6 recruiting, 3 active not recruiting, 1 terminated. 5 Phase 2, 4 Phase 3, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 2, Recruiting 2, Terminated 1 |
| Phase 3 | 4 | Recruiting 2, Active not recruiting 1, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Proton Collaborative Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy Proton Therapy - Breast Cancer | Phase 3 | Recruiting | Proton Collaborative Group | 276 | 2024-03-21 | 2026-09-29 |
| Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas Proton Radiation, Capecitabine, Surgical resection - Pancreatic Cancer | Phase 2 | Recruiting | Proton Collaborative Group | 60 | 2016-04-01 | 2026-09-29 |
| A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer Radiation with Concurrent Chemotherapy - Lung Neoplasms | Phase 1 / Phase 2 | Active not recruiting | Proton Collaborative Group | 32 | 2013-03-01 | 2026-09-29 |
| Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer Proton Radiotherapy - Breast Cancer, Breast Neoplasm | Phase 2 | Recruiting | Proton Collaborative Group | 132 | 2013-02-01 | 2026-09-29 |
| Proton Radiation for Stage II/III Breast Cancer Proton Radiotherapy - Breast Cancer, Breast Neoplasm | Phase 2 | Active not recruiting | Proton Collaborative Group | 220 | 2013-02-01 | 2026-09-29 |
| External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer Luteinizing hormone-releasing hormone (LHRH), Docetaxel, Conformal Radiation Therapy (RT) - Prostate Cancer | Phase 2 / Phase 3 | Terminated | Proton Collaborative Group | 2 | 2012-07-01 | 2016-03-14 |
| Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer Radiation, Androgen Suppression Therapy - Prostate Cancer | Phase 3 | Recruiting | Proton Collaborative Group | 192 | 2012-01-01 | 2026-09-29 |
| Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer Proton Radiation Hypofractionation, Proton Radiation Standard Fractionation - Prostate Cancer | Phase 3 | Active not recruiting | Proton Collaborative Group | 150 | 2010-11-01 | 2026-09-29 |
| Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE, Proton (prostate bed) to 70.2 CGE, IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE - Prostate Cancer | Not applicable | Recruiting | Proton Collaborative Group | 70 | 2009-08-01 | 2026-06-17 |
| Registry Study for Radiation Therapy Outcomes Proton Therapy, Photon Therapy, SRS, Brachytherapy - Neoplasms | Recruiting | Proton Collaborative Group | 50000 | 2009-06-01 | 2026-09-29 |
Neoplasms (4) · Prostatic Neoplasms (4) · Breast Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Pancreatic Neoplasms (1)
Proton Therapy (4) · Goserelin (2) · Leuprolide (2) · Radiation (2) · Brachytherapy (1) · Buserelin (1) · Capecitabine (1) · Docetaxel (1) · Gonadotropin-Releasing Hormone (1) · Protons (1) · Radiotherapy, Intensity-Modulated (1) · Spermine Synthase (1) · Triptorelin Pamoate (1) · luprolide acetate gel depot (1)
United States (10)
Carlos Vargas, MD (4) · Andrew Chang, MD (1) · Brad Hoppe, MD (1) · Eugen Hug, MD (1) · Isabelle Choi, MD (1) · Romaine C. Nichols, MD (1) · Samuel Jean-Baptiste, MD (1)